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DLS analysis.-Dynamic Light Scattering measurements were carried out on an ALV GSC08 correlator working in a cross correlation mode with an Ar + laser operating at λ = 514.5 nm. The output signals were obtained with backscatter detection at an angle of 90° and processed with a digital correlator that computed intensityintensity autocorrelation of the scattered light. Measurements were made in a 1 cm path length round quartz cell maintained at 298 K. Solution samples were filtered through nylon Acrodisc syringe filters (Pall Life Sciences) with 0.2 µm pore size. 
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Small Angle X-Ray Scattering (SAXS) characterization.-Measurements were performed in water solution at a concentration of 10 -6 . The blank was registered with water and this measurement was subtracted to the signal of the sample. The logarithm of the intensity was multiplied by form factor I(Q) corresponding to a spherical shape and was represented versus the parameter q expressed in Å -1 . The spacing can be obtained from d=2π/q. XRD Characterization.-X-ray diffraction was performed in a Panalytical X'Pert PRO diffractometer with Cu (λ=1.54 Å) tube operated at 45 kV, 40 mA, Ni beta filter, programmable divergence and anti-scatter slits working in fixed mode, and fast linear detector (X'Celerator) working in scanning mode. Samples were deposited on "zero background" silicon sample holders and measured in reflection geometry. C 60 -C 60 packing
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Biological assays.-
Production of recombinant viruses
Recombinant viruses were produced in 293T cells. The viral construction was pseudotyped with Zaire Ebola virus (ZEBOV) envelope glycoprotein (GP) or vesicular stomatitis virus envelope GP (VSV-G) and expressed luciferase as a reporter of the infection. 3, 4 One day (18-24 h) before transfection, 5 x 10 6 293T were seeded onto 10 cm plates. Cells were cultured in DMEM medium supplemented with 10% heat-inactivated FBS, 25 mg Gentamycin, 2 mM L-glutamine. Few minutes before transfection, the medium on transfection plates was changed to 9 ml DMEM and chloroquine was added to 25µM final concentration. Transfection reaction with all reagents at room temperature (RT) was prepared in 15 ml tubes: 183 µl of 2M CaCl 2, 500 ng of EBOV-GP or 2 µg of VSV-G, 21 µg of pNL4-3 luc 5 , 1300 µl of H 2 O. Next, 1.5 ml of 2xHBS (Hepes Buffer Saline) pH 7.00 was added quickly to the tubes and bubbled for 30 seconds. HBS/DNA solution was gently dropped onto medium. After 8 hours of incubation at 37º C with 5% CO 2 , medium on transfection plates was changed to 10 ml DMEM and once again one day after transfection to 7 ml DMEM. Transfection supernatants were harvested after 48 h, centrifuged at 1200 rpm for 10 minutes at RT to remove cell debris, and stored frozen at -80° C. 2, 6 
Ebola virus infection experiments
Infection was performed on Jurkat cells (T-lymphocyte cell line) expressing receptor DC-SIGN on its surface. Since Ebola virus does not infect T-lymphocytes, its entry is absolutely dependent on DC-SIGN for infection of Jurkat cells. 4, 7 Jurkat-DC-SIGN cells (2.5 x 10 5 ) were plated into each well of 96-well plate. Cells were incubated at RT for 20 minutes with the carbohydrate-based compounds and then challenged with 5000 TCID (Tissue Culture Infective Dose) of recombinant viruses. After 48 h of incubation cells were washed twice with PBS and assayed with the Luficerase Assay System (Promega, Madison, WI).
The range of concentrations tested for compounds 1a-b and 2a-b was 1 pM -10 µM. As a control, experiment of infection with VSV-G pseudoviruses was performed in the same conditions. Infection with VSV-G is independent of the presence of DC-SIGN receptor.
Statistical analysis
The values of percentage of inhibition of the infection presented on the graph correspond to the mean of 6 independent experiments with error bars corresponding to the standard errors of the mean. The IC 50 s values were estimated using GraphPad Prism v6.0 with a 95% confidence interval and settings for normalize doseresponse curves.
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Toxicity analysis of compounds 1a and 2a.-Hela and Jurkat DC-SIGN cells (2x10 4 and 1x 10 5 /well respectively) were cultured in a 96-well plate with or without (control) 1a or 2a compounds respectively at the indicated concentrations. After 24 hours, cells were washed with culture medium and viability was measured by a colorimetric method (Cell Titer 96 AQueous Non-Radioactive Cell Proliferation Assay, Promega).
In brief, 20 µl of the combined MTS/PMS solution (reagent) was combined with 100 µl of cells in culture medium and further incubated for 2 hours at 37°C in a humidified, 5% CO 2 atmosphere. Absorbance was recorded at 490 nm using an ELISA plate reader.
Cell viability was reported as the percentage of absorbance in treated cells relative to non-treated cells. 
Schematic Ebola infection model

